Abstract
DOP026 Efficacy and safety of dose escalation to tofacitinib 10 mg BID for patients with ulcerative colitis following loss of response on tofacitinib 5 mg BID maintenance therapy: results from OCTAVE open
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have